More radionuclide therapy is better for prostate cancer patients, study suggests
Tuesday, November 1, 2011 - 14:20
in Health & Medicine
For prostate cancer patients with bone metastases, repeated administrations of radionuclide therapy with 188Re-HEDP are shown to improve overall survival rates and reduce pain, according to new research.